32 results on '"Coward, Jermaine I."'
Search Results
2. Data from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
3. Supplementary Table 2 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
4. Supplementary Figure Legends 1-4 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
5. Supplementary Figure 3 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
6. Supplementary Table 1 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
7. Supplementary Figure 4 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
8. Supplementary Figure 2 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
9. Supplementary Figure 1 from A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
10. Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites
11. Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results
12. Disruption of glycogen utilization markedly improves the efficacy of carboplatin against preclinical models of clear cell ovarian carcinoma
13. Therapeutic implications of immune‐profiling and EGFR expression in salivary gland carcinoma
14. Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report
15. Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
16. Therapeutic implications of immune‐profiling and EGFR expression in salivary gland carcinoma.
17. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
18. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer
19. A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
20. Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report
21. Rethinking ovarian cancer: recommendations for improving outcomes
22. New perspectives on targeted therapy in ovarian cancer.
23. High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis.
24. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
25. L1 Retrotransposon Heterogeneity in Ovarian Tumor Cell Evolution.
26. Mucinous ovarian cancer: A therapeutic review.
27. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies.
28. The role of interleukin-6 in malignant mesothelioma.
29. Interleukin-6: an angiogenic target in solid tumours.
30. Chemotherapy advances in small-cell lung cancer.
31. The role of interleukin-6 in gynaecological malignancies.
32. True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.